These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35834242)

  • 1. Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort.
    Fu L; Tai S; Sun J; Zhang N; Zhou Y; Xing Z; Wang Y; Zhou S
    Diabetes Care; 2022 Sep; 45(9):2136-2143. PubMed ID: 35834242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
    Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
    J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of visit-to-visit variability, and maximum and minimum LDL cholesterol in diabetes mellitus.
    Sheng CS; Miao Y; Ding L; Cheng Y; Wang D; Yang Y; Tian J
    Lipids Health Dis; 2022 Feb; 21(1):19. PubMed ID: 35144636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid variability and risk of microvascular complications in Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: A post hoc analysis.
    Hukportie DN; Li FR; Zhou R; Zheng JZ; Wu XX; Zou MC; Wu XB
    J Diabetes; 2022 Jun; 14(6):365-376. PubMed ID: 35668633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive value of low-density lipoprotein cholesterol/remnant cholesterol coordination on cardiovascular and cerebrovascular events in elderly patients with hypertension].
    Qu C; Qi SY; Li X; Gao H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Aug; 51(8):844-850. PubMed ID: 37583333
    [No Abstract]   [Full Text] [Related]  

  • 6. Remnant Cholesterol and Cardiovascular Mortality in Patients With Type 2 Diabetes and Incident Diabetic Nephropathy.
    Yu D; Wang Z; Zhang X; Qu B; Cai Y; Ma S; Zhao Z; Simmons D
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3546-3554. PubMed ID: 34291804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
    Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visit-to-visit variability in LDL- and HDL-cholesterol is associated with adverse events after ST-segment elevation myocardial infarction: A 5-year follow-up study.
    Boey E; Gay GM; Poh KK; Yeo TC; Tan HC; Lee CH
    Atherosclerosis; 2016 Jan; 244():86-92. PubMed ID: 26595903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordant Lipid Pattern and Carotid Atherosclerotic Plaque. Importance of Remnant Cholesterol.
    Masson W; Lobo M; Molinero G; Siniawski D
    Arq Bras Cardiol; 2017 Jun; 108(6):526-532. PubMed ID: 28699976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial.
    Bangalore S; Breazna A; DeMicco DA; Wun CC; Messerli FH;
    J Am Coll Cardiol; 2015 Apr; 65(15):1539-48. PubMed ID: 25881936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
    Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK
    Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remnant cholesterol and the risk of aortic valve calcium progression: insights from the MESA study.
    Li ZH; Hao QY; Zeng YH; Guo JB; Li SC; Gao JW; Yang PZ
    Cardiovasc Diabetol; 2024 Jan; 23(1):20. PubMed ID: 38195550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term visit-to-visit variability in low-density lipoprotein cholesterol is associated with poor cardiovascular and kidney outcomes in patients with primary nephrotic syndrome.
    Lai X; Cui Z; Zhang H; Zhang YM; Wang F; Wang X; Meng LQ; Cheng XY; Liu G; Zhao MH
    Int Urol Nephrol; 2023 Jun; 55(6):1565-1574. PubMed ID: 36648742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.
    Lee EY; Yang Y; Kim HS; Cho JH; Yoon KH; Chung WS; Lee SH; Chang K
    Atherosclerosis; 2018 Dec; 279():1-9. PubMed ID: 30359786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remnant cholesterol predicts cardiovascular mortality beyond low-density lipoprotein cholesterol in patients with peritoneal dialysis.
    Guo J; Peng Y; Liu R; Yi C; Guo Q; Yang X
    J Clin Lipidol; 2023; 17(6):708-716. PubMed ID: 37723014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remnant Cholesterol and the Risk of Coronary Artery Calcium Progression: Insights From the CARDIA and MESA Study.
    Hao QY; Gao JW; Yuan ZM; Gao M; Wang JF; Schiele F; Zhang SL; Liu PM
    Circ Cardiovasc Imaging; 2022 Jul; 15(7):e014116. PubMed ID: 35861979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study.
    Huh JH; Han KD; Cho YK; Roh E; Kang JG; Lee SJ; Ihm SH
    Cardiovasc Diabetol; 2022 Nov; 21(1):228. PubMed ID: 36324177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GREATER LOW-DENSITY LIPOPROTEIN CHOLESTEROL VARIABILITY INCREASES THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.
    Hsu WH; Lai CW; Chen SC; Chiou HC; Hsiao PJ; Shin SJ; Lee MY
    Endocr Pract; 2019 Sep; 25(9):918-925. PubMed ID: 31070951
    [No Abstract]   [Full Text] [Related]  

  • 19. Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
    Waters DD; Bangalore S; Fayyad R; DeMicco DA; Laskey R; Melamed S; Barter PJ
    J Clin Lipidol; 2018; 12(2):356-366. PubMed ID: 29310989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.